Sbi 0206965
SBI-0206965 is a small molecule compound developed by Merck Group. It is a laboratory reagent intended for use in research applications. The core function of SBI-0206965 is to serve as a tool for investigating biological processes and pathways. Further details about its intended use or applications are not available.
Lab products found in correlation
28 protocols using sbi 0206965
Autophagy Modulation in MCF-7 Breast Cancer Cells
AML Mouse Model Treatment Protocol
Preparation and Storage of Experimental Compounds
Autophagy Modulation in Cell Infection
Primary Keratinocyte Isolation and Culture
Transient Transfection and Starvation Assay
BafilomycinA1 (Santa Cruz Biotechnology) was used in a concentration of 200 nM.
For induction of starvation, Earle’s Balanced Salt Solution (EBSS) (Sigma-Aldrich) was used.
The ULK1 inhibitor SBI-0206965 (Sigma-Aldrich) was used in a concentration of 5 µM.
Modulating Autophagy and Cell Signaling
Comprehensive Reagent Toolkit for Cell Death Studies
Culturing Primary Rat Cortical Neurons
Autophagy and Necroptosis Regulation Assays
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!